Status:
COMPLETED
Superficial Cervical Plexus Block for IJCL Pain Management
Lead Sponsor:
Cleveland Clinic Akron General
Conditions:
Superficial Cervical Plexus Block
Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.
Detailed Description
The goal of this study is to determine if SCPBs provide more pain control than local infiltrate of anesthetic for internal jugular venous cannulation. The investigators hypothesis that patients who re...
Eligibility Criteria
Inclusion
- Patients who are 18 years and older, and;
- Present to the Akron General Emergency Department (Main) between March 1, 2021 and December 1, 2022, and;
- Require IJVC as a part of their clinical care.
Exclusion
- Patients who are intubated; or
- Patients who undergo CPR; or
- Patients who have an allergy to lidocaine or bupivacaine; or
- Patients who have a contraindication to receiving a superficial cervical plexus block such as cellulitis over Erb's point or the internal jugular vein, abnormal anatomy, or prior surgery to the area.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05252832
Start Date
January 15 2022
End Date
December 31 2024
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Akron General
Akron, Ohio, United States, 44307